GO:0002834 regulation of response to tumor cell: Immune Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002834 (regulation of response to tumor cell) is a biological process that modulates the frequency, rate, or extent of a response to tumor cell.
• This process is central to tumor immunology, influencing how immune and stromal cells interact with malignant cells.
• Key regulatory mechanisms include endoplasmic reticulum stress signaling, vascular regulation, and metabolic control within the tumor microenvironment.
• Dysregulation of this process contributes to cancer progression, immune evasion, and therapy resistance.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise dissection of genes controlling this process.
• Understanding GO:0002834 aids in identifying therapeutic targets for immunotherapy and combination treatments.
Description
The Gene Ontology (GO) term GO:0002834, regulation of response to tumor cell, describes any process that modulates the frequency, rate, or extent of a response to tumor cell. This biological process is fundamental to tumor immunology, as it governs how immune cells, stromal cells, and other components of the tumor microenvironment react to malignant cells. Researchers study this term to uncover mechanisms of immune evasion, tumor progression, and potential therapeutic interventions. The regulation of response to tumor cell encompasses diverse signaling pathways, including endoplasmic reticulum stress responses and vascular regulatory mechanisms that influence immune cell function within tumors. These processes are critical for understanding why some tumors respond to immunotherapy while others resist, and they provide a framework for developing novel anticancer strategies.
regulation of response to tumor cell At A Glance
| GO ID | GO:0002834 |
|---|---|
| GO term | regulation of response to tumor cell |
| Ontology | biological_process |
| Synonym | regulation of response to tumour cell |
| Major function | Modulates the frequency, rate, or extent of a response to tumor cell |
| Related processes | Immune response, tumor microenvironment signaling, ER stress response |
| Disease relevance | Cancer progression, immune evasion, therapy resistance |
| Research tools | CRISPR knockout, knock-in, overexpression, library screening |
What Is GO:0002834?
GO:0002834 is defined as any process that modulates the frequency, rate, or extent of a response to tumor cell. In simpler terms, it refers to the regulatory mechanisms that control how a cell or organism reacts to the presence of tumor cells, including immune activation, tolerance, or evasion. This regulation can occur at multiple levels, from intracellular signaling to intercellular communication within the tumor microenvironment.
Why Is regulation of response to tumor cell Important in Cell Biology?
Understanding the regulation of response to tumor cell is crucial because it directly impacts cancer progression and treatment outcomes. The tumor microenvironment often hijacks regulatory pathways to suppress immune responses, leading to immune evasion and resistance to therapies. By elucidating these regulatory mechanisms, researchers can identify new targets for immunotherapy and develop strategies to enhance antitumor immunity.
• Governs immune cell activation or suppression in the presence of tumor cells.
• Influences tumor progression and metastasis through microenvironmental crosstalk.
• Plays a role in resistance to immune checkpoint inhibitors.
• Involves endoplasmic reticulum stress signaling that can promote tumor survival or death.
• Vascular regulation within tumors affects immune cell infiltration and function.
• Dysregulation can lead to chronic inflammation or immune tolerance.
• Provides targets for combination therapies in oncology.
• Enables precision medicine approaches by stratifying patients based on regulatory profiles.
• Facilitates development of CRISPR-based models to study gene function.
• Bridges basic immunology with clinical applications in cancer treatment.
What Happens During regulation of response to tumor cell?
Recognition of Tumor Cells
In simple terms: The body's cells first notice that tumor cells are present.
The initial step involves detection of tumor cells by immune cells or stromal cells. This recognition can occur through tumor-associated antigens, danger signals, or stress-induced ligands. Endoplasmic reticulum stress in the tumor microenvironment can release signals that modulate this recognition process. Vascular components also influence how immune cells access and recognize tumor cells.
Signal Transduction and Regulatory Pathways
In simple terms: Signals are sent inside cells to decide how to respond.
Upon recognition, intracellular signaling cascades are activated. These include ER stress response pathways, which can either promote immune activation or suppress it depending on context. Vascular regulatory mechanisms control the expression of adhesion molecules and chemokines that guide immune cell function. These pathways modulate the frequency and extent of the response.
Immune Cell Activation or Suppression
In simple terms: Immune cells are either turned on to attack or turned off to tolerate.
The regulatory process determines whether immune cells become activated to kill tumor cells or are suppressed to promote tolerance. For example, selective immune cell function in the tumor immune response is regulated by vascular mechanisms. ER stress signals can also influence the balance between pro-inflammatory and anti-inflammatory responses.
Effector Functions and Tumor Cell Fate
In simple terms: The final outcome is either tumor cell death or survival.
Depending on the regulatory signals, effector mechanisms such as cytotoxicity, cytokine secretion, or phagocytosis are engaged. These can lead to tumor cell apoptosis or, conversely, promote tumor survival and proliferation. The regulation of response to tumor cell thus directly impacts tumor fate.
Feedback and Resolution
In simple terms: The response is tuned down after the threat is handled.
Regulatory feedback loops prevent excessive or chronic responses. This involves upregulation of inhibitory receptors, secretion of anti-inflammatory cytokines, and remodeling of the tumor microenvironment. Dysregulation of these feedback mechanisms can lead to immune evasion or autoimmunity.
Key Genes Involved in GO:0002834 regulation of response to tumor cell
The following genes and proteins are key players in the regulation of response to tumor cell, based on their roles in ER stress, vascular regulation, and immune modulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HSPA5 (GRP78) | ER stress sensor and regulator | Modulates tumor cell survival and immune recognition |
| ATF6 | ER stress transducer | Controls adaptive responses in tumor microenvironment |
| ERN1 (IRE1) | ER stress sensor | Regulates immune cell function and tumor progression |
| EIF2AK3 (PERK) | ER stress kinase | Influences translation and immune evasion |
| XBP1 | Transcription factor downstream of IRE1 | Drives survival signals in tumor and immune cells |
| VEGFA | Vascular endothelial growth factor | Regulates immune cell infiltration and function |
| KDR (VEGFR2) | VEGF receptor | Mediates vascular effects on immune response |
| ICAM1 | Adhesion molecule | Facilitates immune cell adhesion and migration |
| VCAM1 | Adhesion molecule | Involved in immune cell recruitment |
| CCL2 | Chemokine | Recruits monocytes and macrophages to tumors |
| CXCL10 | Chemokine | Attracts effector T cells |
| IFNG | Cytokine | Activates antitumor immunity |
| TGFB1 | Cytokine | Suppresses immune responses in tumors |
| IL10 | Cytokine | Promotes immune tolerance |
| PDCD1 (PD-1) | Immune checkpoint | Regulates T cell exhaustion |
| CD274 (PD-L1) | Immune checkpoint ligand | Mediates immune evasion |
| CTLA4 | Immune checkpoint | Regulates T cell activation |
How Is regulation of response to tumor cell Regulated?
The regulation of response to tumor cell is controlled by multiple signaling pathways. Endoplasmic reticulum stress signals can modulate both tumor and immune cells, influencing the outcome of the response. Vascular regulatory mechanisms, including VEGF and adhesion molecules, control immune cell extravasation and function within the tumor microenvironment. Additionally, metabolic and hormonal factors, such as those seen in polycystic ovary syndrome, can impact follicular microenvironment and systemic immune responses, though direct links to tumor response regulation require further study.
regulation of response to tumor cell and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HSPA5 | Cancer, ER stress adaptation | Knockout in cancer cell lines |
| VEGFA | Tumor angiogenesis, immune evasion | Overexpression in endothelial cells |
| PDCD1 | Immune checkpoint resistance | Knockout in T cells |
| TGFB1 | Immunosuppression in tumors | Knock-in of constitutively active form |
| XBP1 | Tumor survival, immune modulation | Point mutation to alter splicing |
Cancer Progression and Immune Evasion
Dysregulation of the response to tumor cell is a hallmark of cancer progression. Tumors often exploit ER stress pathways to survive and evade immune detection. Vascular abnormalities within tumors can impair immune cell infiltration, leading to a immunosuppressive microenvironment that supports tumor growth. Targeting these regulatory mechanisms can restore antitumor immunity and improve therapy outcomes.
Therapy Resistance
Resistance to immune checkpoint inhibitors is frequently linked to altered regulation of response to tumor cell. For example, upregulation of PD-L1 or secretion of immunosuppressive cytokines like TGFB1 and IL10 can dampen T cell responses. ER stress-induced survival signals in tumor cells also contribute to resistance to chemotherapy and immunotherapy. Understanding these pathways is essential for developing combination strategies.
Metabolic and Endocrine Disorders
Conditions such as polycystic ovary syndrome (PCOS) involve disturbed follicular microenvironments and systemic inflammation that may influence immune responses. While direct evidence linking PCOS to tumor response regulation is limited, shared pathways such as WNT signaling and AMPK/SIRT1/PDK4 axis suggest potential crosstalk. Further research is needed to establish these connections.
From regulation of response to tumor cell-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate immune response to tumor cells? | CRISPR knockout in immune cells or tumor cells |
| Does a specific mutation in gene Y alter tumor response? | Point mutation knock-in via CRISPR |
| How does overexpression of gene Z affect tumor microenvironment? | CRISPR-mediated overexpression |
| What is the role of a tagged protein in tumor response? | Tagged knock-in for imaging or proteomics |
| Can combinatorial gene edits enhance antitumor immunity? | Multiplex CRISPR library screening |
| Does a SNP in gene A affect response to tumor cells? | Knock-in of SNP variant |
How to Study the regulation of response to tumor cell Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Gene expression changes | Identify regulatory pathways |
| Proteomics | Protein abundance and modifications | Map signaling networks |
| CRISPR screen | Gene function in response | Discover novel regulators |
| Flow cytometry | Immune cell phenotypes | Assess activation status |
| Live-cell imaging | Dynamic interactions | Visualize tumor cell killing |
| ELISA | Cytokine secretion | Quantify immune mediators |
| Western blot | Protein expression and phosphorylation | Validate signaling changes |
Transcriptomic Profiling
RNA sequencing (RNA-seq) can reveal global changes in gene expression during regulation of response to tumor cell. This method identifies pathways and gene signatures associated with immune activation or suppression.
Proteomic and Phosphoproteomic Analysis
Mass spectrometry-based proteomics quantifies protein abundance and post-translational modifications, uncovering signaling nodes in the regulatory process. This is particularly useful for studying ER stress and vascular signaling.
Functional Genomics with CRISPR Screens
CRISPR knockout or activation screens enable unbiased discovery of genes that regulate response to tumor cells. Libraries targeting kinases, transcription factors, or immune modulators can identify novel therapeutic targets.
Imaging and Flow Cytometry
Live-cell imaging and flow cytometry assess immune cell-tumor cell interactions, cytokine secretion, and cytotoxicity. These methods provide spatial and temporal resolution of the regulatory process.
How CRISPR Can Be Used to Study GO:0002834 regulation of response to tumor cell
Knockout
CRISPR knockout is used to delete genes hypothesized to regulate response to tumor cell. For example, knocking out HSPA5 or VEGFA can reveal their roles in immune evasion or vascular regulation. This approach provides causal evidence for gene function.
Point Mutation
Point mutations can be introduced to model specific amino acid changes that alter protein function. This is useful for studying SNPs or oncogenic mutations in genes like XBP1 or PDCD1 that affect tumor response.
Knock-in
Knock-in strategies allow precise insertion of tags, reporters, or humanized sequences. Tagged knock-in of immune checkpoint genes enables real-time tracking of their expression and localization during tumor response.
Overexpression
CRISPR-mediated overexpression (e.g., via CRISPRa) can drive high expression of genes like IFNG or CXCL10 to enhance antitumor immunity. This helps test gain-of-function effects in the regulatory process.
How EDITGENE Supports regulation of response to tumor cell Research
Researchers studying regulation of response to tumor cell-related genes often need to determine whether a candidate gene is causally involved in the process or merely correlated. EDITGENE provides a comprehensive suite of CRISPR services to enable such functional validation with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for regulation of response to tumor cell research.
Frequently Asked Questions About regulation of response to tumor cell
What is GO:0002834?
GO:0002834 is a Gene Ontology term for regulation of response to tumor cell, defined as any process that modulates the frequency, rate, or extent of a response to tumor cell.
What genes are involved in regulation of response to tumor cell?
Key genes include HSPA5, ATF6, ERN1, EIF2AK3, XBP1, VEGFA, KDR, ICAM1, VCAM1, CCL2, CXCL10, IFNG, TGFB1, IL10, PDCD1, CD274, and CTLA4.
How does ER stress regulate response to tumor cells?
ER stress signals can modulate immune recognition and tumor cell survival, influencing the outcome of the response.
What is the role of vascular regulation in tumor immune response?
Vascular mechanisms control immune cell infiltration and function within tumors, affecting the response to tumor cells.
Which diseases are linked to dysregulation of response to tumor cell?
Cancer progression, immune evasion, and therapy resistance are major diseases linked to dysregulation of this process.
How can CRISPR be used to study regulation of response to tumor cell?
CRISPR knockout, point mutation, knock-in, and overexpression models enable functional dissection of genes involved in this process.
What methods are used to study GO:0002834?
RNA-seq, proteomics, CRISPR screens, flow cytometry, and imaging are commonly used to study this process.
What is the definition of response to tumor cell?
Response to tumor cell is any process that results in a change in state or activity of a cell or organism as a result of a tumor cell stimulus.
Why is regulation of response to tumor cell important in cancer therapy?
It determines whether the immune system attacks or tolerates tumors, impacting immunotherapy efficacy.
Can EDITGENE help with CRISPR models for this process?
Yes, EDITGENE provides knockout, point mutation, knock-in, overexpression, and library screening services for genes involved in regulation of response to tumor cell.
Conclusion
GO:0002834 regulation of response to tumor cell is a critical biological process that governs immune and stromal cell interactions with tumors. Dysregulation of this process contributes to cancer progression and therapy resistance, making it a prime target for therapeutic intervention. Advances in CRISPR technology and functional genomics are accelerating the discovery of key regulators and paving the way for novel immunotherapies. Continued research into this process will enhance our understanding of tumor immunology and improve patient outcomes.
References
- 1. Chen X et al.. 2021. Endoplasmic reticulum stress signals in the tumour and its microenvironment.. Nat Rev Cancer 21(2):71-88 PMID: 33214692
- 3. Fu Y et al.. 2024. Mesenchymal stem cell-derived apoptotic vesicles ameliorate impaired ovarian folliculogenesis in polycystic ovary syndrome and ovarian aging by targeting WNT signaling.. Theranostics 14(8):3385-3403 PMID: 38855175
- 4. Welsh M. 2022. Perspectives on Vascular Regulation of Mechanisms Controlling Selective Immune Cell Function in the Tumor Immune Response.. Int J Mol Sci 23(4) PMID: 35216427
- 5. Dai M et al.. 2024. Disturbed Follicular Microenvironment in Polycystic Ovary Syndrome: Relationship to Oocyte Quality and Infertility.. Endocrinology 165(4) PMID: 38375912
- 6. Ji R et al.. 2024. BOP1 contributes to the activation of autophagy in polycystic ovary syndrome via nucleolar stress response.. Cell Mol Life Sci 81(1):101 PMID: 38409361
- 7. Hong L et al.. 2024. Decreased AMPK/SIRT1/PDK4 induced by androgen excess inhibits human endometrial stromal cell decidualization in PCOS.. Cell Mol Life Sci 81(1):324 PMID: 39080028
